FDA-Inspected Site

PrimaPharma Inc

17 FDA inspections are on record for PrimaPharma Inc in San Diego, United States.

483· Form 483 issued

San Diego, United States · Last updated July 9, 2026

Overview

  • 17 FDA inspections are on record.
  • 9 inspections produced a Form 483.
  • The most recent recorded inspection date is 2022-09-22.

At a glance

Inspections

17

Form 483s

9

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
14 Sep 2022 – 22 Sep 2022Human Drugs483View 483 →
21 Feb 2018 – 12 Mar 2018Human Drugs483View 483 →
19 Apr 2017 – 11 May 2017Human Drugs483View 483 →
21 Oct 2014 – 3 Nov 2014Human Drugs483View 483 →
10 Jun 2013 – 18 Jun 2013Human Drugs483View 483 →
9 Feb 2012Not recordedClean
2 Feb 2011Not recorded483View 483 →
1 Sep 2010Not recorded483View 483 →
11 Sep 2009Not recorded483On file
14 May 2008Not recorded483On file
11 May 2007Not recordedClean
28 Feb 2007Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

22 Sep 2022
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Bryan A Galvez, Claudia M Perez-Kasmarski

22 Sep 2022
21 CFR 211.160(b)(4)

Calibration - at intervals, written program, remedial action

Cited by Bryan A Galvez, Claudia M Perez-Kasmarski

22 Sep 2022
21 CFR 211.194(a)

Complete test data included in records

Cited by Bryan A Galvez, Claudia M Perez-Kasmarski

22 Sep 2022
21 CFR 211.22(a)

Authority lacking to review records, investigate errors

Cited by Bryan A Galvez, Claudia M Perez-Kasmarski

22 Sep 2022
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Bryan A Galvez, Claudia M Perez-Kasmarski

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations10x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations8x
21 CFR 211.192Cited across public-safe Form 483 observations7x
21 CFR 211.160(b)Cited across public-safe Form 483 observations4x
21 CFR 211.100(a)Cited across public-safe Form 483 observations3x
21 CFR 211.25(a)Cited across public-safe Form 483 observations3x
21 CFR 211.25(c)Cited across public-safe Form 483 observations3x
21 CFR 211.56(c)Cited across public-safe Form 483 observations3x
21 CFR 211.67(b)(3)Cited across public-safe Form 483 observations3x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.67(a)Cited across public-safe Form 483 observations2x
21 CFR 211.68(a)Cited across public-safe Form 483 observations2x
21 CFR 211.125(a)Cited across public-safe Form 483 observations1x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.184(c)Cited across public-safe Form 483 observations1x
21 CFR 211.186(b)(7)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iii)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.46(b)Cited across public-safe Form 483 observations1x
21 CFR 211.48(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(6)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(c)(6)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind PrimaPharma Inc's 9 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat